Clear Eyes Advanced Dry and Itchy

Description

Clear Eyes ADVANCED™ is a sterile formulation of glycerin-based lubricant eye drops designed to provide relief from dry and itchy eyes. Each bottle contains 0.5 fluid ounces (15 mL) of the solution, which is intended for use in alleviating discomfort associated with dry eye conditions.

Uses and Indications

This drug is indicated for the temporary relief of burning and irritation due to dryness of the eye. It serves as a protectant against further irritation and is effective in alleviating symptoms associated with dry eyes.

There are no teratogenic or nonteratogenic effects mentioned in the available data.

Dosage and Administration

Healthcare professionals are advised to instill 1 or 2 drops of the medication in the affected eye(s) as needed. The frequency of administration should be determined based on the clinical condition of the patient and the response to treatment. It is important to ensure that the drops are administered in a sterile manner to prevent contamination.

Contraindications

Use of this product is contraindicated if the solution changes color or becomes cloudy. This alteration may indicate degradation of the product, which could compromise safety and efficacy.

Warnings and Precautions

For external use only. The product should not be utilized if the solution exhibits any changes in color or becomes cloudy, as this may indicate a compromise in its integrity.

Healthcare professionals should advise patients to discontinue use and seek medical attention if they experience any of the following symptoms: eye pain, changes in vision, persistent redness or irritation of the eye, worsening of the condition, or if symptoms persist for more than 72 hours. These signs may indicate a more serious underlying issue that requires further evaluation.

In the event of accidental ingestion, it is imperative to seek emergency medical assistance immediately or contact a Poison Control Center at 1-800-222-1222. Prompt action is essential to ensure patient safety and appropriate management of the situation.

Side Effects

Patients should discontinue use and consult a healthcare professional if they experience any of the following serious adverse reactions: eye pain, changes in vision, continued redness or irritation of the eye, worsening of the condition, or if symptoms persist for more than 72 hours. These reactions warrant immediate medical attention to ensure appropriate evaluation and management.

Drug Interactions

No drug interactions or drug and laboratory test interactions have been identified in the available data. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Clear Eyes Advanced Dry and Itchy (glycerin). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center (1-800-222-1222) should be contacted without delay.

Geriatric Use

Elderly patients may use Clear Eyes Advanced Dry and Itchy Eye Drops; however, the prescribing information does not provide specific guidance regarding geriatric use, dosage adjustments, safety concerns, or special precautions for this population.

Healthcare providers should exercise caution when recommending this product to geriatric patients, as the absence of specific data necessitates careful monitoring for any potential adverse effects or interactions. It is advisable to consider the overall health status and any comorbidities of elderly patients when determining the appropriateness of this treatment.

Pregnancy

There is no specific information regarding the use of Clear Eyes Advanced Dry and Itchy Eye Drops during pregnancy. As such, the potential risks and benefits of using this product in pregnant patients have not been established. Healthcare professionals should exercise caution when recommending this product to women of childbearing potential and consider alternative treatments that have been studied in pregnant populations. It is advisable to discuss any concerns with patients regarding the use of this product during pregnancy.

Lactation

Nursing mothers should consult a healthcare professional before using this product. There is a potential for excretion in breast milk; therefore, caution is advised when administering to nursing mothers. The effects on the nursing infant are not well studied; thus, the risks versus benefits should be considered.

Renal Impairment

Patients with renal impairment may not have specific information regarding dosage adjustments, special monitoring, or safety considerations outlined in the prescribing information. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment and monitoring of these patients.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help without delay. It is recommended to contact a Poison Control Center at 1-800-222-1222 for expert guidance on managing the situation.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Healthcare providers should be prepared to assess the patient's condition and implement appropriate management strategies based on the severity of symptoms and the specific substance involved.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Patients should be advised to seek immediate medical assistance or contact a Poison Control Center at 1-800-222-1222 if the product is swallowed. It is important to inform patients that they should not use the product if the solution changes color or becomes cloudy, as this may indicate a loss of efficacy or safety.

Healthcare providers should instruct patients to discontinue use and consult a doctor if they experience any of the following: eye pain, changes in vision, continued redness or irritation of the eye, or if their condition worsens. Additionally, patients should be made aware that if symptoms persist for more than 72 hours, they should stop using the product and seek medical advice.

To ensure safe usage, patients should be counseled on the importance of avoiding contamination. They should be instructed not to touch the tip of the product to any surface and to replace the cap immediately after use to maintain the integrity of the solution.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at room temperature to maintain its integrity and efficacy. No special handling requirements are noted; however, standard precautions should be observed to ensure optimal storage conditions.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Clear Eyes Advanced Dry and Itchy, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)